Skip to main content

Table 3 Survival analysis, according to Cox regression

From: Management of patients with pulmonary mycobacteriosis in France: a multicenter retrospective cohort study

  Non adjusted HR [CI 95%] p Adjusted HR
[CI 95%]
p
Age 1.02 [1.01–1.04] 0.02 1.02 [1.01–1.04] 0.04
Female 0.73 [0.42–1.27] 0.27   
Respiratory diseases 0.99 [0.54–1.83] 0.99   
Past mycobacterial diseases 1.56 [0.89–2.71] 0.11   
Cavitary disease 0.84 [0.42–1.66] 0.61   
Positive smear 1.33 [0.78–2.26] 0.30   
NTM specie
 MAC Reference   Reference  
 M. xenopi 1.33 [0.68–2.60] 0.40 1.21 [0.59–2.49] 0.61
 M. abscessus 2.64 [1.03–6.78] 0.04 3.19 [1.22–8.32] 0.02
 M. kansasii 0.69 [0.16–2.88] 0.61 1.12 [0.20–3.45] 0.83
 Others 1.16 [0.41–3.29] 0.78 1.02 [1.01–1.04] 0.83
Treatment 0.47 [0.27–0 .83] 0.009 C [0.28–0.92] 0.03